Surrogate end points for prostate cancer: what is prostate-specific antigen telling us?
- PMID: 13130102
- DOI: 10.1093/jnci/djg071
Surrogate end points for prostate cancer: what is prostate-specific antigen telling us?
Comment on
-
Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy.J Natl Cancer Inst. 2003 Sep 17;95(18):1376-83. doi: 10.1093/jnci/djg043. J Natl Cancer Inst. 2003. PMID: 13130113
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
